Novel approaches to identify protective malaria vaccine candidates

Frontiers in Microbiology

Volumn 5, Issue NOV, 2014, Pages

  Chia, Wan Ni ^a,b   Goh, Yun Shan ^a   Rénia, Laurent ^a,b  

^a AGENCY FOR SCIENCE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Antibodies; Library; Malaria; Screen; Vaccine

Indexed keywords

ANTIBODY; ANTIGEN; ANTISERUM; APICAL MEMBRANE ANTIGEN 1; BACTERIUM LYSATE; CIRCUMSPOROZOITE PROTEIN; ERYTHROCYTE ANTIGEN; GAMMA INTERFERON; GENOMIC DNA; IMMUNOGLOBULIN G; MALARIA VACCINE; PFRH5 PROTEIN; RECOMBINANT PROTEIN; RING ERYTHROCYTE SURFACE ANTIGEN; UNCLASSIFIED DRUG;

CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DISEASE COURSE; GENE SEQUENCE; GENETIC SCREENING; HOST PARASITE INTERACTION; HUMAN; IMMUNE RESPONSE; MALARIA; MALARIA CONTROL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PARASITE CLEARANCE; PLASMODIUM FALCIPARUM; PROTEIN MICROARRAY; REVIEW; SPOROZOITE; VACCINATION;

PLASMODIUM FALCIPARUM;

EID: 84920607648     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00586     Document Type: Review

References (110)

1. Agnandji, S. T., Lell, B., Fernandes, J. F., Abossolo, B. P., Methogo, B. G., Kabwende, A. L.,et al. (2012). A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants. N. Engl. J. Med. 367, 2284-2295. doi: 10.1056/NEJMoa1208394
2. Agnandji, S. T., Lell, B., Soulanoudjingar, S. S., Fernandes, J. F., Abossolo, B. P., Conzelmann, C.,et al. (2011). First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children. N. Engl. J. Med. 365, 1863-1875. doi: 10.1056/NEJMoa1102287
3. Amino, R., Thiberge, S., Martin, B., Celli, S., Shorte, S., Frischknecht, F.,et al. (2006). Quantitative imaging of Plasmodium transmission from mosquito to mammal. Nat. Med. 12, 220-224. doi: 10.1038/nm1350
4. Anders, R. F. (1986). Multiple cross-reactivities amongst antigens of Plasmodium falciparum impair the development of protective immunity against malaria. Parasite Immunol. 8, 529-539. doi: 10.1111/j.1365-3024.1986.tb00867.x
5. Anders, R. F., Coppel, R. L., Brown, G. V., Saint, R. B., Cowman, A. F., Lingelbach, K. R.,et al. (1984). Plasmodium falciparum complementary DNA clones expressed in Escherichia coli encode many distinct antigens. Mol. Biol. Med. 2, 177-191.
6. Ardeshir, F., Flint, J. E., and Reese, R. T. (1985). Expression of Plasmodium falciparum surface antigens in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 82, 2518-2522. doi: 10.1073/pnas.82.8.2518
7. Ashley, E. A., Dhorda, M., Fairhurst, R. M., Amaratunga, C., Lim, P., Suon, S.,et al. (2014). Spread of artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 371, 411-423. doi: 10.1056/NEJMoa1314981
8. Baer, K., Klotz, C., Kappe, S. H., Schnieder, T., and Frevert, U. (2007). Release of hepatic Plasmodium yoelii merozoites into the pulmonary microvasculature. PLoS Pathog. 3:e171. doi: 10.1371/journal.ppat.0030171
9. Barry, A. E., Trieu, A., Fowkes, F. J., Pablo, J., Kalantari-Dehaghi, M., Jasinskas, A.,et al. (2011). The stability and complexity of antibody responses to the major surface antigen of Plasmodium falciparum are associated with age in a malaria endemic area. Mol. Cell. Proteomics 10:M111. doi: 10.1074/mcp. M111.008326
10. Baum, E., Badu, K., Molina, D. M., Liang, X., Felgner, P. L., and Yan, G. (2013). Protein microarray analysis of antibody responses to Plasmodium falciparum in western Kenyan highland sites with differing transmission levels. PLoS ONE 8:e82246. doi: 10.1371/journal.pone.0082246
11. Bejon, P., White, M. T., Olotu, A., Bojang, K., Lusingu, J. P., Salim, N.,et al. (2013). Efficacy of RTS, S malaria vaccines: individual-participant pooled analysis of phase 2 data. Lancet Infect. Dis. 13, 319-327. doi: 10.1016/S1473-3099(13)70005-7
12. Belnoue, E., Kayibanda, M., Vigario, A. M., Deschemin, J. C., Van Rooijen, N., Viguier, M.,et al. (2002). On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. J. Immunol. 169, 6369-6375. doi: 10.4049/jimmunol.169.11.6369
13. Belnoue, E., Voza, T., Costa, F. T., Gruner, A. C., Mauduit, M., Rosa, D. S.,et al. (2008). Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage. J. Immunol. 181, 8552-8558. doi: 10.4049/jimmunol.181.12.8552
14. Bottius, E., Benmohamed, L., Brahimi, K., Gras, H., Lepers, J. P., Raharimalala, L.,et al. (1996). A novel Plasmodium falciparum sporozoite and liver stage antigen (SALSA) defines major B, T helper, and CTL epitopes. J. Immunol. 156, 2874-2884.
15. Bouharoun-Tayoun, H., Oeuvray, C., Lunel, F., and Druilhe, P. (1995). Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J. Exp. Med. 182, 409-418. doi: 10.1084/jem.182.2.409
16. Bozdech, Z., Llinas, M., Pulliam, B. L., Wong, E. D., Zhu, J., and Derisi, J. L. (2003). The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum. PLoS Biol. 1:E5. doi: 10.1371/journal.pbio.0000005
17. Brown, G. V., Anders, R. F., Coppel, R. L., Saint, R. B., Cowman, A. F., Stahl, H. D.,et al. (1984). The expression of Plasmodium falciparum bloodstage antigens in Escherichia coli. Philos. Trans. R. Soc. Lond. B Biol. Sci. 307, 179-187. doi: 10.1098/rstb.1984.0118
18. Butler, N. S., Vaughan, A. M., Harty, J. T., and Kappe, S. H. (2012). Whole parasite vaccination approaches for prevention of malaria infection. Trends Immunol. 33, 247-254. doi: 10.1016/j.it.2012.02.001
19. Carlton, J. M., Angiuoli, S. V., Suh, B. B., Kooij, T. W., Pertea, M., Silva, J. C.,et al. (2002). Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. Nature 419, 512-519. doi: 10.1038/nature01099
20. CDC. (2012). Impact of Malaria [Online]. Available at: http://www.cdc.gov/malaria/malaria_worldwide/impact.html [Accessed Feb 14, 2014].
21. Chia, W., Asm, O., Ksw, T., Preiser, P., and Renia, L. (2014). "Defining immune correlates of protection against malaria using Plasmodium yoelii mouse models," in Australian Society of Parasitology Annual Conference, Canberra.
22. Clyde, D. F., Most, H., Mccarthy, V. C., and Vanderberg, J. P. (1973). Immunization of man against sporozite-induced falciparum malaria. Am. J. Med. Sci. 266, 169-177. doi: 10.1097/00000441-197309000-00002
23. Cockburn, I. A., Amino, R., Kelemen, R. K., Kuo, S. C., Tse, S. W., Radtke, A.,et al. (2013). In vivo imaging of CD8+ T cell-mediated elimination of malaria liver stages. Proc. Natl. Acad. Sci. U.S.A. 110, 9090-9095. doi: 10.1073/pnas.1303858110
24. Cohen, S., Mc, G. I., and Carrington, S. (1961). Gamma-globulin and acquired immunity to human malaria. Nature 192, 733-737. doi: 10.1038/192733a0
25. Crompton, P. D., Kayala, M. A., Traore, B., Kayentao, K., Ongoiba, A., Weiss, G. E.,et al. (2010). A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc. Natl. Acad. Sci. U.S.A. 107, 6958-6963. doi: 10.1073/pnas.1001323107
26. Crosnier, C., Bustamante, L. Y., Bartholdson, S. J., Bei, A. K., Theron, M., Uchikawa, M.,et al. (2011). Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum. Nature 480, 534-537. doi: 10.1038/nature10606
27. Daubersies, P., Thomas, A. W., Millet, P., Brahimi, K., Langermans, J. A., Ollomo, B.,et al. (2000). Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3. Nat. Med. 6, 1258-1263. doi: 10.1038/81366
28. Doolan, D. L. (2011). Plasmodium immunomics. Int. J. Parasitol. 41, 3-20. doi: 10.1016/j.ijpara.2010.08.002
29. Doolan, D. L., and Hoffman, S. L. (2000). The complexity of protective immunity against liver-stage malaria. J. Immunol. 165, 1453-1462. doi: 10.4049/jimmunol.165.3.1453
30. Doolan, D. L., Mu, Y., Unal, B., Sundaresh, S., Hirst, S., Valdez, C.,et al. (2008). Profiling humoral immune responses to Plasmodium falciparum infection with protein microarrays. Proteomics 8, 4680-4694. doi: 10.1002/pmic.200800194
31. Doolan, D. L., Southwood, S., Freilich, D. A., Sidney, J., Graber, N. L., Shatney, L.,et al. (2003). Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proc. Natl. Acad. Sci. U.S.A. 100, 9952-9957. doi: 10.1073/pnas.1633254100
32. Dutta, S., Haynes, J. D., Barbosa, A., Ware, L. A., Snavely, J. D., Moch, J. K.,et al. (2005). Mode of action of invasion-inhibitory antibodies directed against apical membrane antigen 1 of Plasmodium falciparum. Infect. Immun. 73, 2116-2122. doi: 10.1128/IAI.73.4.2116-2122.2005
33. Ellis, J., Ozaki, L. S., Gwadz, R. W., Cochrane, A. H., Nussenzweig, V., Nussenzweig, R. S.,et al. (1983). Cloning and expression in E. coli of the malarial sporozoite surface antigen gene from Plasmodium knowlesi. Nature 302, 536-538. doi: 10.1038/302536a0
34. Fidock, D. A., Sallenave-Sales, S., Sherwood, J. A., Gachihi, G. S., Ferreira-Da-Cruz, M. F., Thomas, A. W.,et al. (1994). Conservation of the Plasmodium falciparum sporozoite surface protein gene, STARP, in field isolates and distinct species of Plasmodium. Mol. Biochem. Parasitol. 67, 255-267. doi: 10.1016/0166-6851(94)00138-3
35. Finney, O. C., Keitany, G. J., Smithers, H., Kaushansky, A., Kappe, S., and Wang, R. (2014). Immunization with genetically attenuated Plasmodium falciparum parasites induces long-lived antibodies that efficiently block hepatocyte invasion by sporozoites. Vaccine 32, 2135-2138. doi: 10.1016/j.vaccine.2014.02.055
36. Florens, L., Washburn, M. P., Raine, J. D., Anthony, R. M., Grainger, M., Haynes, J. D.,et al. (2002). A proteomic view of the Plasmodium falciparum life cycle. Nature 419, 520-526. doi: 10.1038/nature01107
37. Frevert, U., Moreno, A., Calvo-Calle, M., Klotz, C., and Nardin, E. H. (2009). Imaging effector functions of human cytotoxic CD4+ T cells specific for Plasmodium falciparum circumsporozoite protein. Int. J. Parasitol. 39, 119-132. doi: 10.1016/j.ijpara.2008.06.014
38. Friesen, J., Silvie, O., Putrianti, E. D., Hafalla, J. C., Matuschewski, K., and Borrmann, S. (2010). Natural immunization against malaria: causal prophylaxis with antibiotics. Sci. Transl. Med. 2, 40-49. doi: 10.1126/scitranslmed.3001058
39. Gardner, M. J., Hall, N., Fung, E., White, O., Berriman, M., Hyman, R. W.,et al. (2002). Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419, 498-511. doi: 10.1038/nature01097
40. Gruner, A. C., Brahimi, K., Eling, W., Konings, R., Meis, J., Aikawa, M.,et al. (2001a). The Plasmodium falciparum knob-associated PfEMP3 antigen is also expressed at pre-erythrocytic stages and induces antibodies which inhibit sporozoite invasion. Mol. Biochem. Parasitol. 112, 253-261. doi: 10.1016/S0166-6851(00)00373-X
41. Gruner, A. C., Brahimi, K., Letourneur, F., Renia, L., Eling, W., Snounou, G.,et al. (2001b). Expression of the erythrocyte-binding antigen 175 in sporozoites and in liver stages of Plasmodium falciparum. J. Infect. Dis. 184, 892-897. doi: 10.1086/323394
42. Gruner, A. C., Snounou, G., Brahimi, K., Letourneur, F., Renia, L., and Druilhe, P. (2003). Pre-erythrocytic antigens of Plasmodium falciparum: from rags to riches? Trends Parasitol. 19, 74-78. doi: 10.1016/j.ijpara.2004.05.005
43. Guerin-Marchand, C., Druilhe, P., Galey, B., Londono, A., Patarapotikul, J., Beaudoin, R. L.,et al. (1987). A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning. Nature 329, 164-167. doi: 10.1038/329164a0
44. Gupta, S., Snow, R. W., Donnelly, C. A., Marsh, K., and Newbold, C. (1999). Immunity to non-cerebral severe malaria is acquired after one or two infections. Nat. Med. 5, 340-343. doi: 10.1038/6560
45. Haddad, D., Bilcikova, E., Witney, A. A., Carlton, J. M., White, C. E., Blair, P. L.,et al. (2004). Novel antigen identification method for discovery of protective malaria antigens by rapid testing of DNA vaccines encoding exons from the parasite genome. Infect. Immun. 72, 1594-1602. doi: 10.1128/IAI.72.3.1594-1602.2004
46. Hall, N., Karras, M., Raine, J. D., Carlton, J. M., Kooij, T. W., Berriman, M.,et al. (2005). A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses. Science 307, 82-86. doi: 10.1126/science.1103717
47. Hall, N., Pain, A., Berriman, M., Churcher, C., Harris, B., Harris, D.,et al. (2002). Sequence of Plasmodium falciparum chromosomes 1, 3-9 and 13. Nature 419, 527-531. doi: 10.1038/nature01095
48. Hoffman, S. L., Goh, L. M., Luke, T. C., Schneider, I., Le, T. P., Doolan, D. L.,et al. (2002). Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J. Infect. Dis. 185, 1155-1164. doi: 10.1086/339409
49. Horne-Debets, J. M., Faleiro, R., Karunarathne, D. S., Liu, X. Q., Lineburg, K. E., Poh, C. M.,et al. (2013). PD-1 dependent exhaustion of CD8+ T cells drives chronic malaria. Cell Rep. 5, 1204-1213. doi: 10.1016/j.celrep.2013.11.002
50. Jiang, L., Gaur, D., Mu, J., Zhou, H., Long, C. A., and Miller, L. H. (2011). Evidence for erythrocyte-binding antigen 175 as a component of a ligand-blocking blood-stage malaria vaccine. Proc. Natl. Acad. Sci. U.S.A. 108, 7553-7558. doi: 10.1073/pnas.1104050108
51. Kamali, A. N., Marin-Garcia, P., Azcarate, I. G., Diez, A., Puyet, A., and Bautista, J. M. (2012). Plasmodium yoelii blood-stage antigens newly identified by immunoaffinity using purified IgG antibodies from malaria-resistant mice. Immunobiology 217, 823-830. doi: 10.1016/j.imbio.2012.05.002
52. Kappe, S. H., Gardner, M. J., Brown, S. M., Ross, J., Matuschewski, K., Ribeiro, J. M.,et al. (2001). Exploring the transcriptome of the malaria sporozoite stage. Proc. Natl. Acad. Sci. U.S.A. 98, 9895-9900. doi: 10.1073/pnas.171185198
53. Kappe, S. H., Noe, A. R., Fraser, T. S., Blair, P. L., and Adams, J. H. (1998). A family of chimeric erythrocyte binding proteins of malaria parasites. Proc. Natl. Acad. Sci. U.S.A. 95, 1230-1235. doi: 10.1073/pnas.95.3.1230
54. Kemp, D. J., Coppel, R. L., and Anders, R. F. (1987). Repetitive proteins and genes of malaria. Annu. Rev. Microbiol. 41, 181-208. doi: 10.1146/annurev.mi.41.100187.001145
55. Kemp, D. J., Coppel, R. L., Cowman, A. F., Saint, R. B., Brown, G. V., and Anders, R. F. (1983). Expression of Plasmodium falciparum blood-stage antigens in Escherichia coli: detection with antibodies from immune humans. Proc. Natl. Acad. Sci. U.S.A. 80, 3787-3791. doi: 10.1073/pnas.80.12.3787
56. Kemp, D. J., Coppel, R. L., Stahl, H. D., Bianco, A. E., Corcoran, L. M., Mcintyre, P.,et al. (1986). The wellcome trust lecture. Genes for antigens of Plasmodium falciparum. Parasitology 92(Suppl.), S83-S108. doi: 10.1017/S0031182000085711
57. Khan, S. M., Franke-Fayard, B., Mair, G. R., Lasonder, E., Janse, C. J., Mann, M.,et al. (2005). Proteome analysis of separated male and female gametocytes reveals novel sex-specific Plasmodium biology. Cell 121, 675-687. doi: 10.1016/j.cell.2005.03.027
58. Kooij, T. W., Carlton, J. M. R., Bidwell, S. L., Hall, N., Ramesar, J., Janse, C. J.,et al. (2005). A Plasmodium whole-genome synteny map: indels and synteny breakpoints as foci for species-specific genes. PLoS Pathog. 1:e44. doi: 10.1371/journal.ppat.0010044
59. Langhorne, J. (1994). The immune response to the blood stages of Plasmodium in animal models. Immunol. Lett. 41, 99-102. doi: 10.1016/0165-2478(94)90115-5
60. Langhorne, J., Ndungu, F. M., Sponaas, A. M., and Marsh, K. (2008). Immunity to malaria: more questions than answers. Nat. Immunol. 9, 725-732. doi: 10.1038/ni.f.205
61. Lasonder, E., Ishihama, Y., Andersen, J. S., Vermunt, A. M., Pain, A., Sauerwein, R. W.,et al. (2002). Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry. Nature 419, 537-542. doi: 10.1038/nature01111
62. Le Roch, K. G., Zhou, Y., Batalov, S., and Winzeler, E. A. (2002). Monitoring the chromosome 2 intraerythrocytic transcriptome of Plasmodium falciparum using oligonucleotide arrays. Am. J. Trop. Med. Hyg. 67, 233-243.
63. Lindner, S. E., Swearingen, K. E., Harupa, A., Vaughan, A. M., Sinnis, P., Moritz, R. L.,et al. (2013). Total and putative surface proteomics of malaria parasite salivary gland sporozoites. Mol. Cell. Proteomics 12, 1127-1143. doi: 10.1074/mcp. M112.024505
64. Lu, F., Li, J., Wang, B., Cheng, Y., Kong, D. H., Cui, L.,et al. (2014). Profiling the humoral immune responses to Plasmodium vivax infection and identification of candidate immunogenic rhoptry-associated membrane antigen (RAMA). J. Proteomics 6, 66-82. doi: 10.1016/j.jprot.2014.02.029
65. Marchand, C., and Druilhe, P. (1990). How to select Plasmodium falciparum pre-erythrocytic antigens in an expression library without defined probe. Bull. World Health Organ. 68(Suppl.), 158-164.
66. Marsh, K., and Kinyanjui, S. (2006). Immune effector mechanisms in malaria. Parasite Immunol. 28, 51-60. doi: 10.1111/j.1365-3024.2006.00808.x
67. Mehlin, C., Boni, E., Buckner, F. S., Engel, L., Feist, T., Gelb, M. H.,et al. (2006). Heterologous expression of proteins from Plasmodium falciparum: results from 1000 genes. Mol. Biochem. Parasitol. 148, 144-160. doi: 10.1016/j.molbiopara.2006.03.011
68. Michon, P., Fraser, T., and Adams, J. H. (2000). Naturally acquired and vaccine-elicited antibodies block erythrocyte cytoadherence of the Plasmodium vivax Duffy binding protein. Infect. Immun. 68, 3164-3171. doi: 10.1128/IAI.68.6.3164-3171.2000
69. Molina, D. M., Finney, O. C., Arevalo-Herrera, M., Herrera, S., Felgner, P. L., Gardner, M. J.,et al. (2012). Plasmodium vivax pre-erythrocytic-stage antigen discovery: exploiting naturally acquired humoral responses. Am. J. Trop. Med. Hyg. 87, 460-469. doi: 10.4269/ajtmh.2012.12-0222
70. Moorthy, V. S., Good, M. F., and Hill, A. V. (2004). Malaria vaccine developments. Lancet 363, 150-156. doi: 10.1016/S0140-6736(03)15267-1
71. Mueller, A. K., Labaied, M., Kappe, S. H., and Matuschewski, K. (2005). Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 433, 164-167. doi: 10.1038/nature03188
72. Nussenzweig, R. S., Vanderberg, J., Most, H., and Orton, C. (1967). Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature 216, 160-162. doi: 10.1038/216160a0
73. Offeddu, V., Thathy, V., Marsh, K., and Matuschewski, K. (2012). Naturally acquired immune responses against Plasmodium falciparum sporozoites and liver infection. Int. J. Parasitol. 42, 535-548. doi: 10.1016/j.ijpara.2012.03.011
74. Olotu, A., Fegan, G., Wambua, J., Nyangweso, G., Awuondo, K. O., Leach, A.,et al. (2013). Four-year efficacy of RTS, S/AS01E and its interaction with malaria exposure. N. Engl. J. Med. 368, 1111-1120. doi: 10.1056/NEJMoa1207564
75. Osier, F. H., Mackinnon, M. J., Crosnier, C., Fegan, G., Kamuyu, G., Wanaguru, M.,et al. (2014). New antigens for a multicomponent blood-stage malaria vaccine. Sci. Transl. Med. 6, 247-102. doi: 10.1126/scitranslmed.3008705
76. Overstreet, M. G., Cockburn, I. A., Chen, Y. C., and Zavala, F. (2008). Protective CD8 T cells against Plasmodium liver stages: immunobiology of an 'unnatural' immune response. Immunol. Rev. 225, 272-283. doi: 10.1111/j.1600-065X.2008.00671.x
77. Phyo, A. P., Nkhoma, S., Stepniewska, K., Ashley, E. A., Nair, S., Mcgready, R.,et al. (2012). Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet 379, 1960-1966. doi: 10.1016/S0140-6736(12)60484-X
78. Raj, D. K., Nixon, C. P., Nixon, C. E., Dvorin, J. D., Dipetrillo, C. G., Pond-Tor, S.,et al. (2014). Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection. Science 344, 871-877. doi: 10.1126/science.1254417
79. Rathore, D., Nagarkatti, R., Jani, D., Chattopadhyay, R., De La Vega, P., Kumar, S.,et al. (2005). An immunologically cryptic epitope of Plasmodium falciparum circumsporozoite protein facilitates liver cell recognition and induces protective antibodies that block liver cell invasion. J. Biol. Chem. 280, 20524-20529. doi: 10.1074/jbc. M414254200
80. Renia, L., Grillot, D., Marussig, M., Corradin, G., Miltgen, F., Lambert, P. H.,et al. (1993). Effector functions of circumsporozoite peptide-primed CD4+ T cell clones against Plasmodium yoelii liver stages. J. Immunol. 150, 1471-1478.
81. Renia, L., Gruner, A. C., Mauduit, M., and Snounou, G. (2006). Vaccination against malaria with live parasites. Expert Rev. Vaccines 5, 473-481. doi: 10.1586/14760584.5.4.473
82. Renia, L., Marussig, M. S., Grillot, D., Pied, S., Corradin, G., Miltgen, F.,et al. (1991). In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide. Proc. Natl. Acad. Sci. U.S.A. 88, 7963-7967. doi: 10.1073/pnas.88.18.7963
83. Renia, L., Mattei, D., Goma, J., Pied, S., Dubois, P., Miltgen, F.,et al. (1990). A malaria heat-shock-like determinant expressed on the infected hepatocyte surface is the target of antibody-dependent cell-mediated cytotoxic mechanisms by nonparenchymal liver cells. Eur. J. Immunol. 20, 1445-1449. doi: 10.1002/eji.1830200706
84. Richards, J. S., Arumugam, T. U., Reiling, L., Healer, J., Hodder, A. N., Fowkes, F. J.,et al. (2013). Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development. J. Immunol. 191, 795-809. doi: 10.4049/jimmunol.1300778
85. Richards, W. H. (1966). Antimalarial activity of sulphonamides and a sulphone, singly and in combination with pyrimethamine, against drug resistant and normal strains of laboratory plasmodia. Nature 212, 1494-1495. doi: 10.1038/2121494a0
86. Rieckmann, K. H., Carson, P. E., Beaudoin, R. L., Cassells, J. S., and Sell, K. W. (1974). Letter: sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 68, 258-259. doi: 10.1016/0035-9203(74)90129-1
87. Robson, K. J., Frevert, U., Reckmann, I., Cowan, G., Beier, J., Scragg, I. G.,et al. (1995). Thrombospondin-related adhesive protein (TRAP) of Plasmodium falciparum: expression during sporozoite ontogeny and binding to human hepatocytes. EMBO J. 14, 3883-3894.
88. Rodriguez, L. E., Curtidor, H., Urquiza, M., Cifuentes, G., Reyes, C., and Patarroyo, M. E. (2008). Intimate molecular interactions of Plasmodium falciparum merozoite proteins involved in invasion of red blood cells and their implications for vaccine design. Chem. Rev. 108, 3656-3705. doi: 10.1021/cr068407v
89. Roestenberg, M., Mccall, M., Hopman, J., Wiersma, J., Luty, A. J., Van Gemert, G. J.,et al. (2009). Protection against a malaria challenge by sporozoite inoculation. N. Engl. J. Med. 361, 468-477. doi: 10.1056/NEJMoa0805832
90. Rui, E., Fernandez-Becerra, C., Takeo, S., Sanz, S., Lacerda, M. V., Tsuboi, T.,et al. (2011). Plasmodium vivax: comparison of immunogenicity among proteins expressed in the cell-free systems of Escherichia coli and wheat germ by suspension array assays. Malar. J. 10, 192. doi: 10.1186/1475-2875-10-192
91. Schofield, L., and Mueller, I. (2006). Clinical immunity to malaria. Curr. Mol. Med. 6, 205-221. doi: 10.2174/156652406776055221
92. Seder, R. A., Chang, L. J., Enama, M. E., Zephir, K. L., Sarwar, U. N., Gordon, I. J.,et al. (2013). Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 341, 1359-1365. doi: 10.1126/science.1241800
93. Sheehy, S. H., Duncan, C. J., Elias, S. C., Choudhary, P., Biswas, S., Halstead, F. D.,et al. (2012). ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans. Mol. Ther. 20, 2355-2368. doi: 10.1038/mt.2012.223
94. Silvie, O., Franetich, J. F., Charrin, S., Mueller, M. S., Siau, A., Bodescot, M.,et al. (2004). A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites. J. Biol. Chem. 279, 9490-9496. doi: 10.1074/jbc. M311331200
95. Singh, N., Preiser, P., Renia, L., Balu, B., Barnwell, J., Blair, P.,et al. (2004). Conservation and developmental control of alternative splicing in maebl among malaria parasites. J. Mol. Biol. 343, 589-599. doi: 10.1016/j.jmb.2004.08.047
96. Spring, M., Murphy, J., Nielsen, R., Dowler, M., Bennett, J. W., Zarling, S.,et al. (2013). First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers. Vaccine 31, 4975-4983. doi: 10.1016/j.vaccine.2013.08.007
97. Spring, M. D., Cummings, J. F., Ockenhouse, C. F., Dutta, S., Reidler, R., Angov, E.,et al. (2009). Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A. PLoS ONE 4:e5254. doi: 10.1371/journal.pone.0005254
98. Stahl, H. D., Coppel, R. L., Brown, G. V., Saint, R., Lingelbach, K., Cowman, A. F.,et al. (1984). Differential antibody screening of cloned Plasmodium falciparum sequences expressed in Escherichia coli: procedure for isolation of defined antigens and analysis of human antisera. Proc. Natl. Acad. Sci. U.S.A. 81, 2456-2460. doi: 10.1073/pnas.81.8.2456
99. Stevenson, M. M., and Riley, E. M. (2004). Innate immunity to malaria. Nat. Rev. Immunol. 4, 169-180. doi: 10.1038/nri1311
100. Sturm, A., Amino, R., Van De Sand, C., Regen, T., Retzlaff, S., Rennenberg, A.,et al. (2006). Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids. Science 313, 1287-1290. doi: 10.1126/science.1129720
101. Tachibana, S., Sullivan, S. A., Kawai, S., Nakamura, S., Kim, H. R., Goto, N.,et al. (2012). Plasmodium cynomolgi genome sequences provide insight into Plasmodium vivax and the monkey malaria clade. Nat. Genet. 44, 1051-1055. doi: 10.1038/ng.2375
102. Tarun, A. S., Peng, X., Dumpit, R. F., Ogata, Y., Silva-Rivera, H., Camargo, N.,et al. (2008). A combined transcriptome and proteome survey of malaria parasite liver stages. Proc. Natl. Acad. Sci. U.S.A. 105, 305-310. doi: 10.1073/pnas.0710780104
103. Taylor-Robinson, A. W. (2010). Regulation of immunity to Plasmodium: implications from mouse models for blood stage malaria vaccine design. Exp. Parasitol. 126, 406-414. doi: 10.1016/j.exppara.2010.01.028
104. Trape, J. F., Tall, A., Diagne, N., Ndiath, O., Ly, A. B., Faye, J.,et al. (2011). Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study. Lancet Infect. Dis. 11, 925-932. doi: 10.1016/S1473-3099(11)70194-3
105. Trieu, A., Kayala, M. A., Burk, C., Molina, D. M., Freilich, D. A., Richie, T. L.,et al. (2011). Sterile protective immunity to malaria is associated with a panel of novel Plasmodium falciparum antigens. Mol. Cell. Proteomics 10, M111 007948. doi: 10.1074/mcp. M111.007948
106. Trimnell, A., Takagi, A., Gupta, M., Richie, T. L., Kappe, S. H., and Wang, R. (2009). Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes. J. Immunol. 183, 5870-5878. doi: 10.4049/jimmunol.0900302
107. Tsuboi, T., Takeo, S., Iriko, H., Jin, L., Tsuchimochi, M., Matsuda, S.,et al. (2008). Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates. Infect. Immun. 76, 1702-1708. doi: 10.1128/IAI.01539-07
108. Vanderberg, J. P., and Frevert, U. (2004). Intravital microscopy demonstrating antibody-mediated immobilization of Plasmodium berghei sporozoites injected into skin by mosquitoes. Int. J. Parasitol. 34, 991-996. doi: 10.1016/j.ijpara.2004.05.005
109. WHO. (2012). Malaria Vaccine Rainbow Tables. Available at: www.who.int/vaccine_research/links/Rainbow/en/index.html [accessed June 30, 2014].
110. Wykes, M. N., and Good, M. F. (2009). What have we learnt from mouse models for the study of malaria? Eur. J. Immunol. 39, 2004-2007. doi: 10.1002/eji.200939552